Leukotriene B₄ 12-hydroxydehydrogenase/15-ketoprostaglandinΔ13-reductase (LTB₄ 12-HD/PGR) responsible for the reduction of a double-bond of the α,β-unsaturated ketone of an aryl propionic acid non-steroidal anti-inflammatory agent CS-670

References

• Adams SS, Bresloff P, Mason CG. Pharmacological differences between the optical isomers of ibuprofen; evidence for metabolic inversion of (–)-isomer. Journal of Pharmacy and Pharmacology 1976; 28: 256–257
   PubMed Web of Science ®Google Scholar
• Asami M, Shigeta A, Tanaka Y. Disposition of CS-670, a novel nonsteroidal anti-inflammatory drug, and its metabolites in healthy human volunteers. Chirality 1996; 8: 207–213
   PubMed Web of Science ®Google Scholar
• Asami M, Takasaki W, Iwabuchi H, Haruyama H, Wachi K, Terada A, Tanaka Y. Stereospecific taurine conjugation of the trans-OH metabolite (active metabolite) of CS-670, a new 2-arylpropionic acid nonsteroidal anti-inflammatory drug, in dogs. Biological and Pharmaceutical Bulletin 1995c; 18: 1584–1589
   PubMedGoogle Scholar
• Asami M, Yamamura M, Nakajima E, Takasaki W, Tanaka Y, Ohtsuki T, Takaichi M, Mitsui T, Yokoshima T. Metabolic studies on CS-670, a new 2-arylpropionic acid nonsteroidal anti-inflammatory drug (1): Absorption, metabolism and excretion of 14C-CS-670 in mice, rats and dogs. Yakubutu Doutai 1995a; 10: 637–650
   Google Scholar
• Asami M, Yamamura M, Takasaki W, Tanaka Y. Quantitative determination of diol metabolites of CS-670, a new anti-inflammatory agent, by capillary column gas chromatography-mass spectrometry. Journal of Chromatography B 1995b; 665: 107–116
   PubMed Web of Science ®Google Scholar
• Clish CB, Levy BD, Chiang N, Tai H-H, Serhan CN. Oxidoreductases in lipoxin A4 metabolic inactivation. Journal of Biological Chemistry 2000; 275: 25372–25380
   PubMed Web of Science ®Google Scholar
• Clish CB, Sun Y-P, Serhan CN. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB4 dehydrogenase. Biochemical and Biophysical. Research Communications 2001; 288: 868–874
   Google Scholar
• Dick RA, Kwak M-K, Sutter TR, Kensler TW. Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. Journal of Biological Chemistry 2001; 276: 40803–40810
   PubMed Web of Science ®Google Scholar
• Ensor CM, Tai HH. 15-Hydroxyprostaglandin dehydrogenase. Journal of Lipid Mediated Cell Signal 1995; 12: 313–319
   PubMedGoogle Scholar
• Ensor CM, Zhang H, Tai HH. Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung. Biochemical Journal. 1998; 330: 103–108
   PubMedGoogle Scholar
• Hori T, Yokomizo T, Ago H, Sugahara M, Ueno G, Yamamoto M, Kumasaka T, Shimizu T, Miyano M. Structural basis of leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop. Journal of Biological Chemistry 2004; 279: 22615–22623
   PubMed Web of Science ®Google Scholar
• Iizuka Y, Kojima T, Nakamizo S, Yamaguchi T, Sato Y, Kobayashi K, Ashiba T, Fujibayashi K, Misaka E. Anti-inflammatory, analgesic and antipyretic activities of CS-670 (RS-2131) {2-[4-(2-oxocyclohexlidenemethyl)phenyl]propionic acid}. Annual Report of Sankyo Research Laboratories 1987; 39: 77–111
   Google Scholar
• Kaiser DG, Van-Giessen GJ, Reischer RJ, Wechter WJ. Isomeric inversion of ibuprofen-(R)-enantiomer in humans. Journal of Pharmacological Sciences 1976; 65: 269–273
   PubMed Web of Science ®Google Scholar
• Kitamura S, Katsura H, Tastumi K. Purification of a 15-ketoprostaglandin Δ 13-reductase from rat liver and its ability to reduce the double-bond of xenobiotics. Biochemistry and Molecular Biology International 1993; 30: 839–847
   PubMedGoogle Scholar
• Kitamura S, Katsura H, Tastumi K. Multiplicity of rat liver 15-ketoprostaglandin Δ 13-reductase. Prostaglandins 1996; 52: 35–49
   PubMedGoogle Scholar
• Kitamura S, Tatsumi K. Purification of NADPH-linked α,β-ketoalkene double-bond reductase from rat liver. Arches of Biochemistry and Biophysics 1990; 282: 183–187
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Abe C, Iizuka Y, Shiokawa Y. Immunomodulation by RS-2131, a new non-steroidal anti-inflammatory drug. Immunopharmacology 1986; 12: 213–220
   PubMedGoogle Scholar
• Lindstrom TD, Whitaker GW. α,β -Ketoalkene reduction: A novel reduction pathway in mammalian tissues. Drug Metabolism and Disposition 1983; 12: 72–76
   Google Scholar
• Lindstrom TD, Whitaker GW. Saturation of an α,β-unsaturated ketone: A novel xenobiotic biotransformation in mammals. Xenobiotica 1984; 14: 503–508
   PubMed Web of Science ®Google Scholar
• Matsuda K, Ohnishi K, Sha T, Yamazaki M, Tanaka Y, Tanaka K. CS-600, a new anti-inflammatory agent. Inhibitory activity on prostaglandin biosynthesis. Japanese Journal of Inflammation 1982a; 2: 263–266
   Google Scholar
• Matsuda K, Tanaka Y, Ushiyama S, Ohnishi K, Yamazaki M. Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo. Biochemical Pharmacology 1982b; 33: 2473–2478
   Google Scholar
• Misaka E, Yamaguchi T, Iizuka Y, Kamoshida K, Kojima T, Kobayashi K, Endo Y, Misawa Y, Kobayashi S, Tanaka K. Anti-inflammatory, analgesic and antipyretic activities of sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (CS-600). Pharmacometrics 1981; 21: 753–771
   Google Scholar
• Surh YJ, Lee SS. Enzymatic reduction of shogaol: A novel biotransformation pathway for the α,β-unsaturated ketone system. Biochemical International 1992; 27: 179–187
   PubMedGoogle Scholar
• Surh YJ, Lee SS. Enzymatic reduction of xenobiotic α,β-unsaturated ketones: Formation of ally alcohol metabolites from shogaol and dehydroparadol. Research Communications in Chemical Pathological and Pharmacology 1994; 84: 53–61
   PubMedGoogle Scholar
• Terada A, Naruto S, Wachi K, Tanaka S, Iizuka Y, Misaka E. Synthesis and anti-inflammatory activity of cycloalkyl methylphenyl acetic acids and related compounds. Journal of Medicinal Chemistry 1984; 27: 212–216
   PubMed Web of Science ®Google Scholar
• Yokomizo T, Izumi T, Takahashi T, Kasama T, Kobayashi Y, Sato F, Taketani Y, Shimizu T. Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leukotriene B4 12-hydroxydehydrogenase. Journal of Biological Chemistry 1993; 268: 18128–18135
   PubMedGoogle Scholar